CYTK
Cytokinetics Inc
$84.88
-0.68 (-0.79%)
At close · Jul 8
Market Cap
$10.56B
Shares
124,432,565
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$88.04M
+376.6%
FY2025
Net Income
-$784.96M
-33.2%
FY2025
Operating Margin
-695.44%
+2207.3pp
FY2025
Diluted EPS
-$6.54
-24.3%
FY2025
Operating Cash Flow
-$510.01M
-28.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 | FY2002 | FY2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $105.82M | $88.04M | $18.47M | $7.53M | $94.59M | $70.43M | $55.83M | $26.87M | $31.5M | $13.37M | $106.41M | $28.66M | $46.94M | $30.65M | $7.56M | $4M | $2.58M | $81.54M | — | — | — | — | — | — | — | — | |
| $413.29M | $416.03M | $339.41M | $330.12M | $240.81M | $159.94M | $96.95M | $86.13M | $89.14M | $90.3M | $59.9M | $46.4M | $44.43M | $49.45M | $35.64M | $37.18M | $38.01M | $39.84M | — | — | — | — | — | — | — | — | |
| — | $284.27M | $215.31M | $173.61M | $177.98M | $96.8M | $52.82M | $39.61M | $31.28M | $36.47M | $27.82M | $19.67M | $17.27M | $15.09M | $12.43M | $13.59M | $14.2M | $15.63M | — | — | — | — | — | — | — | — | |
| — | $10.13M | $9.53M | $11.89M | $5.81M | $2.28M | $1.83M | $1.29M | $1.24M | $1.92M | $741K | $589K | $490K | $433K | $591K | $1.3M | $1.9M | $2.02M | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | $0 | $0 | -$56K | $1.19M | — | -$23K | — | — | — | — | — | — | — | — | |
| $746.06M | $700.3M | $554.72M | $503.74M | $418.79M | $256.74M | $149.77M | $125.74M | $120.42M | $126.76M | $87.72M | $66.07M | $61.69M | $64.54M | — | — | — | — | — | — | — | — | — | — | — | — | |
| $59.2M | — | — | — | — | — | — | — | — | — | — | — | $61.69M | $64.54M | $48.02M | $51.96M | $52.21M | $55.44M | — | — | — | — | — | — | — | — | |
| -$640.25M | -$612.26M | -$536.25M | -$496.21M | -$324.2M | -$186.31M | -$93.94M | -$98.87M | -$88.92M | -$113.4M | $18.69M | -$37.41M | -$14.75M | -$33.89M | -$40.46M | -$47.96M | -$49.64M | $26.1M | — | — | — | — | — | — | — | — | |
| — | -695.44% | -2902.72% | -6589.71% | -342.75% | -264.54% | -168.27% | -367.97% | -282.26% | -848.26% | 17.56% | -130.53% | -31.43% | -110.59% | -535.22% | -1199.1% | -1926.08% | 32% | — | — | — | — | — | — | — | — | |
| — | -$602.13M | -$526.72M | -$484.31M | -$318.39M | -$184.04M | -$92.11M | -$97.57M | -$87.68M | -$111.48M | $19.43M | -$36.82M | -$14.26M | -$33.46M | -$39.87M | -$46.67M | -$47.74M | $28.12M | — | — | — | — | — | — | — | — | |
| — | $45.58M | $37.7M | $28.31M | $19.41M | $16.44M | $15.96M | $6.62M | $3.8M | $3.02M | $2.7M | $268K | $0 | $0 | $3000 | $35K | $176K | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | $11.4M | $1M | $5.3M | $4.5M | $4.2M | — | $449K | $156K | $101K | $96K | $83K | $132K | $318K | — | — | — | — | — | — | — | — | — | |
| $45.74M | $48.42M | $51.53M | $27.63M | $11.34M | $331K | $5.33M | $4.54M | $4.19M | $2.6M | $464K | $174K | $108K | $177K | $87K | $104K | $172K | -$1.4M | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | -$106.29M | -$127.79M | $16.45M | -$37.5M | -$14.65M | -$33.72M | -$40.37M | -$47.86M | -$49.46M | $24.69M | — | — | — | — | — | — | — | — | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$176K | $150K | — | — | — | — | — | — | — | — | |
| -$829.61M | -$784.96M | -$589.53M | -$526.24M | -$388.96M | -$215.31M | -$127.29M | -$121.69M | -$106.29M | -$127.79M | $16.45M | -$37.5M | -$14.65M | -$33.72M | -$40.37M | -$47.86M | -$49.29M | $24.54M | -$56.37M | -$48.89M | -$57.12M | -$42.25M | -$37.2M | -$32.69M | -$23.08M | -$15.87M | |
| — | -891.6% | -3191.11% | -6988.63% | -411.21% | -305.72% | -228% | -452.93% | -337.41% | -955.94% | 15.46% | -130.86% | -31.2% | -110.01% | -534.07% | -1196.5% | -1912.57% | 30.1% | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | -$14.65M | -$33.72M | -$41.68M | -$50.72M | -$49.29M | $24.54M | — | — | — | — | — | — | — | — | |
| -$832.77M | -$786.72M | -$587.12M | -$522.66M | -$391.68M | -$216.33M | -$127.82M | -$121.51M | -$106.13M | -$127.58M | $16.44M | -$37.35M | -$14.66M | -$33.73M | -$40.36M | -$47.85M | -$49.29M | $24.53M | -$56.36M | -$48.82M | -$57.18M | -$42.08M | -$37.43M | -$32.68M | -$23.31M | -$15.68M | |
| USD/shares | — | -$6.54 | -$5.26 | -$5.45 | -$4.33 | -$2.80 | -$1.97 | — | — | -$2.59 | $0.41 | -$0.97 | -$0.41 | — | — | -$0.72 | -$0.77 | $0.43 | — | — | — | — | — | — | — | — |
| USD/shares | — | -$6.54 | -$5.26 | -$5.45 | -$4.33 | -$2.80 | -$1.97 | — | — | -$2.59 | $0.39 | -$0.97 | -$0.41 | — | — | -$0.72 | -$0.77 | $0.42 | — | — | — | — | — | — | — | — |
| shares | — | 120.1K | 111.98K | 96.52K | 89.83K | 76.89K | 64.52K | 57.58K | 54.42K | 49.4M | 39.94M | 38.81M | 35.71M | 27.28M | 108.64M | 70.8M | 64.29M | 57.39M | — | — | — | — | — | — | — | — |
| shares | — | 120.1K | 111.98K | 96.52K | 89.83K | 76.89K | 64.52K | 57.58K | 54.42K | 49.4M | 42.56M | 38.81M | 35.71M | 27.28M | 18.11M | 70.8M | 64.17M | 57.96M | — | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Showing the latest 26 of 27 periods — chart a line item for full history.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2011–FY2012: $136K in buybacks.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| License and Milestone Revenues | $79,353,000 | $15,000,000 | $3,500,000 | $1,000,000 | $54,900,000 | — | — | — |
| Collaboration Revenues | $8,686,000 | $3,474,000 | $4,030,000 | $6,588,000 | — | — | — | — |
| Milestone | — | — | — | — | $5,000,000 | $2,800,000 | $0 | $0 |
| Realization Of Revenue Participation Right Purchase Agreement | — | — | — | $87,000,000 | $0 | $0 | — | — |
| Research And Development | — | — | — | — | $10,572,000 | $16,527,000 | $26,868,000 | $26,368,000 |
| License | — | — | — | — | $54,900,000 | $36,501,000 | $0 | $5,133,000 |
Key facts
CIK
1061983
CUSIP
23282W605
13F (30d)
13 filings
12 filers
Visit website
Investor relations